US Bancorp DE acquired a new stake in shares of Arteris, Inc. (NASDAQ:AIP – Free Report) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 4,419 shares of the company’s stock, valued at approximately $34,000.
Other institutional investors and hedge funds have also made changes to their positions in the company. Vanguard Group Inc. lifted its stake in Arteris by 0.3% in the first quarter. Vanguard Group Inc. now owns 1,146,224 shares of the company’s stock valued at $8,390,000 after buying an additional 3,242 shares during the last quarter. Renaissance Technologies LLC grew its stake in shares of Arteris by 6.1% in the second quarter. Renaissance Technologies LLC now owns 114,700 shares of the company’s stock worth $861,000 after purchasing an additional 6,600 shares in the last quarter. The Manufacturers Life Insurance Company acquired a new position in shares of Arteris during the second quarter valued at $86,000. Algert Global LLC bought a new stake in shares of Arteris during the second quarter valued at about $115,000. Finally, Rhumbline Advisers lifted its holdings in Arteris by 2,182.8% in the second quarter. Rhumbline Advisers now owns 31,822 shares of the company’s stock worth $239,000 after purchasing an additional 30,428 shares during the period. 64.36% of the stock is owned by institutional investors and hedge funds.
Arteris Price Performance
Shares of NASDAQ:AIP opened at $7.84 on Tuesday. The company’s fifty day moving average is $7.38 and its two-hundred day moving average is $7.73. The company has a market cap of $315.01 million, a P/E ratio of -8.17 and a beta of 1.13. Arteris, Inc. has a 12-month low of $4.65 and a 12-month high of $9.54. The company has a quick ratio of 1.16, a current ratio of 1.16 and a debt-to-equity ratio of 0.30.
Insider Activity
Analyst Upgrades and Downgrades
A number of research firms have weighed in on AIP. Rosenblatt Securities restated a “buy” rating and issued a $15.00 target price on shares of Arteris in a research report on Wednesday, November 6th. Westpark Capital restated a “buy” rating and issued a $11.00 price objective on shares of Arteris in a report on Wednesday, July 31st.
Read Our Latest Analysis on Arteris
Arteris Company Profile
Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.
Read More
- Five stocks we like better than Arteris
- When to Sell a Stock for Profit or Loss
- Is Monolithic Power Systems a Screaming Buy After Near 40% Drop?
- What Does Downgrade Mean in Investing?
- Applied Materials Market Capitulates: Now is the Time to Buy
- How to Buy Cheap Stocks Step by Step
- 3 Ultra-High Dividend Yield Stocks for the New Year
Want to see what other hedge funds are holding AIP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Arteris, Inc. (NASDAQ:AIP – Free Report).
Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.